US, EU filings for Eisai’s lenvatinib in liver cancer

26th July 2017 Uncategorised 0

Eisai has filed its anticancer drug lenvatinib for liver cancer on both sides of the Atlantic as it seeks to expand the drug’s list of approved uses.

More: US, EU filings for Eisai’s lenvatinib in liver cancer
Source: News